Office of Dietary Supplements outlines five-year strategic plan

By Stephen Daniells

- Last updated on GMT

© iStock/Zoran Zeremski
© iStock/Zoran Zeremski

Related tags Dietary supplements Dietary supplement Office of dietary supplements

Creating and disseminating analytic tools for biomarkers, seeking to better understand the microbiome, and enhancing consumer to the Dietary Supplement Label Database are just some of the new directions outlined by the Office of Dietary Supplements for 2017-2021.

The National Institutes of Health’s Office of Dietary Supplements released its 2017-21 strategic plan last month, and the document outlines some examples of new directions the office will take over the next five years, including:

1. Coordinating the creation and dissemination of analytical tools to expand beyond measuring nutrient ingredients in supplements to include the identification and measurement of biomarkers of nutrient exposure and status in blood and how these relate to chronic disease risk;

2. Seeking to understand how the microbiome changes or influences the effects of bioactives in food and dietary supplements;

3. Evaluating and developing tools to more precisely assess dietary supplement usage patterns, including large health surveys in specific populations;

4. Launching mobile versions of the Dietary Supplement Label Database (DSLD) to enhance consumer access;

5. Expanding its research practicum to increase participation, possibly with a live webcast of future events; and

6. Exploring additional mechanisms to support postdoctoral research training.

“ODS’s prioritization of activities is an ongoing process, continuing beyond the strategic planning period, and is based on research opportunities and public health needs,” ​states the document.

To read the full document, please click HERE​. 

ODS research portfolio 2015
Source: Office of Dietary Supplements Strategic Plan 2017-2021

Related news

Related products

show more

Harness the power of algae for omega-3 innovation

Harness the power of algae for omega-3 innovation

Content provided by dsm-firmenich | 22-May-2024 | Insight Guide

Algal-sourced omega-3s have limitless potential, able to scale to meet the needs of our planet’s population with twice the potency – naturally – and all...

Effera™ Human Equivalent Lactoferrin

Effera™ Human Equivalent Lactoferrin

Content provided by Helaina Inc | 17-May-2024 | Product Brochure

Helaina’s bioactive protein Effera™ is a novel branded ingredient and the first clinically studied Human Lactoferrin on the market. Human Lactoferrin is...

Related suppliers

Follow us


View more